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EDITORIAL
Nephritis promoted by oxidative injury
Systemic lupus erythematosus, an inflammatory dis- the development of nephritis in the NZB mouse [4].
Other examples of experimental nephritis suggest thatease of unknown cause, is characterized by immunologi-
overexpression of specific genes (e.g., bcl-2, IL-4) cancal injury to diverse tissues, including skin, serosal sur-
attenuate lymphocyte apoptosis and impede differentia-faces, and the kidneys. Although the specific pathogenetic
tion toward TH1 cell-mediated immunity, thus favoringmechanisms are incompletely understood, development
inappropriate cell survival, autoreactivity, and immuno-of the disorder appears to require polyclonal activation
globulin overproduction [5, 6]. While the genetic back-of B and T lymphocytes, production of autoantibodies
ground of different murine strains contributes to thedirected against specific nuclear and cytosolic antigens,
development and progression of renal diseases, the vari-and immune complex deposition [1]. In the kidney, such
ous models underscore the central roles of immune cellimmune complex deposition within the glomerular mes-
survival and activitation, as well as differentiation alongangium and along the subendothelial and subepithelial
TH2 pathways with its associated overproduction of dis-margins of the basement membrane seems to be a critical
ease-specific autoantibodies.event that sets an inflammatory cascade in motion. These
Although immune cells are key in initiating the eventsetiopathogenic mechanisms are, in turn, modulated by
of immune complex renal disease, other pro-inflamma-a complex interplay of genetic, environmental, and hor-
tory and remodeling pathways likely modulate the pro-monal factors that ultimately determine the spectrum
gression and maturation of these lesions. For example,and severity of disease.
lymphocyte activation may result in downstream effects,Our understanding of how these diverse factors con-
including increased production of pro-inflammatory cyto-
tribute to disease progression has advanced in recent kines, angiogenic growth factors, and reactive oxygen spe-
years through investigations with several experimental cies [7]. These later events may be the crucial regulators
models that resemble, if not recapitulate, lupus. As most of matrix deposition and parenchymal scarring and could
of these are characterized by a proliferative glomerulo- ultimately turn an acute, reversible inflammatory lesion
nephritis, such models are proving to be especially valu- into one of irreversible fibrosis. In this issue of Kidney
able in elucidating how specific immune defects contrib- International, Yoh et al demonstrate that targeted dele-
ute to renal disease and suggest potential candidate genes tion of the basic leucine zipper protein Nrf2, a transcrip-
and mechanisms for study in human nephritis. Histori- tion activator for several antioxidant enzymes, results in
cally, while efforts have focused on experimental murine the development of an immune complex nephritis in
strains that spontaneously develop a lupus-like syn- aged female ICR mice [8]. These mice demonstrate sev-
drome (e.g., NZB/W F1, MRL/lpr, and BXSB), trans- eral immunopathological features of human lupus, in-
genic techniques extend these studies and identify other cluding splenomegaly, proteinuria, production of ANA
pathways that lead to the development of immune dys- and anti-dsDNA antibodies, mesangial and capillary de-
regulation with autoreactivity and immune complex ne- position of IgG, IgM and C3 complement with subsequent
phritis. Each of the models, in turn, suggests a potential proliferative/crescentic change within glomeruli, and, even-
tually, renal failure and death. These findings suggestingmechanism by which the disease evolves and allows the
a role for oxidant stress in the development of lupus areunique opportunity to directly test if targeted therapies
supported by previous work by other investigators show-modulate renal survival, and how such specific defects
ing that knockouts of specific antioxidant genes down-potentiate progression of other autoimmune models.
stream from Nrf2 also develop a crescentic glomerulone-Targeted gene deletion of components known crucial
phritis [9], as well as observations that supplementationto immune cell pathways has generated rodents with
with omega-3 fatty acids generally upregulate antioxidantautoreactivity and nephritis. Examples include defects in
enzyme gene expression and ameliorate nephritis in thesrc tyrosine kinases [2] and transforming growth factor-
NZB/W model [10].(TGF-) [3]. In addition, the blockade of tumor necrosis
However, it is important to be cautious in assumingfactor (TNF) pathways has also been shown to accelerate
the Nrf2 gene is critical to the development of lupus ne-
phritis de novo, as several important features distinguish
this model from well-established “lupus-like” strains. First,Key words: systemic lupus erythematosus, B and T lymphocytes, prolif-
erative glomerulonephritis. the appearance of clinically detectable nephritis occurs
quite late in these animals, usually after 60 weeks of age, 2001 by the International Society of Nephrology
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much beyond the time frame demonstrated in other Correspondence to Victor M. Byrd, M.D., Vanderbilt University
Medical Center, Division of Rheumatology, T 3219 MCN, 21st Ave andmodels such as NZB/W and MRL/lpr. In addition, the
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ICR strain itself shows an intrinsic predisposition toward E-mail: victor.byrd@mcmail.vanderbilt.edu
the delayed development of nephritis and produces anti-
dsDNA antibodies at detectable levels [8, 11]. The likely
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